{
  "iri": "http://purl.obolibrary.org/obo/NCIT_C1563",
  "lang": "en",
  "description": [
    "The R-enantiomer of the calcium channel blocker verapamil. Dexverapamil competitively inhibits the multidrug resistance efflux pump P-glycoprotein (MDR-1), thereby potentially increasing the effectiveness of a wide range of antineoplastic drugs which are inactivated by MDR-1 mechanisms.  This agent exhibits decreased calcium antagonistic activity and toxicity compared to racemic verapamil. (NCI04)"
  ],
  "synonyms": [
    "R Verapamil",
    "R-Verapamil",
    "Dexverapamil",
    "DEXVERAPAMIL"
  ],
  "annotation": {
    "CAS_Registry": [
      "38321-02-7"
    ],
    "Chemical_Formula": [
      "C27H38N2O4"
    ],
    "Contributing_Source": [
      "FDA"
    ],
    "FDA_UNII_Code": [
      "QR5PYD126V"
    ],
    "Legacy Concept Name": [
      "Dexverapamil"
    ],
    "NCI_Drug_Dictionary_ID": [
      "41269"
    ],
    "PDQ_Closed_Trial_Search_ID": [
      "41269"
    ],
    "PDQ_Open_Trial_Search_ID": [
      "41269"
    ],
    "Preferred_Name": [
      "Dexverapamil"
    ],
    "Semantic_Type": [
      "Pharmacologic Substance",
      "Organic Chemical"
    ],
    "UMLS_CUI": [
      "C0280858"
    ],
    "code": [
      "C1563"
    ]
  },
  "label": "Dexverapamil",
  "ontology_name": "ncit",
  "ontology_prefix": "NCIT",
  "ontology_iri": "http://purl.obolibrary.org/obo/ncit.owl",
  "is_obsolete": false,
  "term_replaced_by": null,
  "is_defining_ontology": true,
  "has_children": false,
  "is_root": false,
  "short_form": "NCIT_C1563",
  "obo_id": "NCIT:C1563",
  "in_subset": [
    "NCIT_C176424",
    "NCIT_C63923"
  ],
  "obo_definition_citation": [
    {
      "definition": "The R-enantiomer of the calcium channel blocker verapamil. Dexverapamil competitively inhibits the multidrug resistance efflux pump P-glycoprotein (MDR-1), thereby potentially increasing the effectiveness of a wide range of antineoplastic drugs which are inactivated by MDR-1 mechanisms.  This agent exhibits decreased calcium antagonistic activity and toxicity compared to racemic verapamil. (NCI04)",
      "oboXrefs": [
        {
          "database": null,
          "id": "NCI",
          "description": null,
          "url": null
        }
      ]
    }
  ],
  "obo_xref": null,
  "obo_synonym": [
    {
      "name": "DEXVERAPAMIL",
      "scope": "hasExactSynonym",
      "type": null,
      "xrefs": []
    },
    {
      "name": "R Verapamil",
      "scope": "hasExactSynonym",
      "type": null,
      "xrefs": []
    },
    {
      "name": "R-Verapamil",
      "scope": "hasExactSynonym",
      "type": null,
      "xrefs": []
    },
    {
      "name": "Dexverapamil",
      "scope": "hasExactSynonym",
      "type": null,
      "xrefs": []
    }
  ],
  "is_preferred_root": false,
  "_links": {
    "self": {
      "href": "https://www.ebi.ac.uk/ols/api/ontologies/ncit/terms/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FNCIT_C1563?lang=en"
    },
    "parents": {
      "href": "https://www.ebi.ac.uk/ols/api/ontologies/ncit/terms/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FNCIT_C1563/parents"
    },
    "ancestors": {
      "href": "https://www.ebi.ac.uk/ols/api/ontologies/ncit/terms/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FNCIT_C1563/ancestors"
    },
    "hierarchicalParents": {
      "href": "https://www.ebi.ac.uk/ols/api/ontologies/ncit/terms/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FNCIT_C1563/hierarchicalParents"
    },
    "hierarchicalAncestors": {
      "href": "https://www.ebi.ac.uk/ols/api/ontologies/ncit/terms/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FNCIT_C1563/hierarchicalAncestors"
    },
    "jstree": {
      "href": "https://www.ebi.ac.uk/ols/api/ontologies/ncit/terms/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FNCIT_C1563/jstree"
    },
    "graph": {
      "href": "https://www.ebi.ac.uk/ols/api/ontologies/ncit/terms/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FNCIT_C1563/graph"
    }
  },
  "errors": [],
  "warnings": []
}
